167 related articles for article (PubMed ID: 22459174)
1. Synthesis, cytotoxicity and structure-activity relationships between ester and amide functionalities in novel acridine-based platinum(II) complexes.
Bouyer F; Moretto J; Pertuit D; Szollosi A; Lacaille-Dubois MA; Blache Y; Chauffert B; Desbois N
J Inorg Biochem; 2012 May; 110():51-7. PubMed ID: 22459174
[TBL] [Abstract][Full Text] [Related]
2. Platinum(II) complexes containing long-chain hydrophobic N-alkyl-diamine ligands: synthesis, characterization, molecular modeling, and cytotoxic activity.
Tavares TT; Teixeira GF; Lopes CM; Novato WT; Silva H; Lopes MT; De Almeida MV; Grazul RM; Dos Santos HF; Fontes AP
J Inorg Biochem; 2012 Oct; 115():13-9. PubMed ID: 22922288
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
[TBL] [Abstract][Full Text] [Related]
5. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
6. How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindole.
Štarha P; Trávníček Z; Popa A; Popa I; Muchová T; Brabec V
J Inorg Biochem; 2012 Oct; 115():57-63. PubMed ID: 22922312
[TBL] [Abstract][Full Text] [Related]
7. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro cytotoxicity of novel lipophilic (diamine)platinum(II) complexes of salicylate derivatives.
Ye QS; Lou LG; Liu WP; Yu Y; Chen XZ; Hou SQ; Gao WQ; Liu Y
Bioorg Med Chem Lett; 2007 Apr; 17(8):2146-9. PubMed ID: 17306532
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes.
Zhang J; Li Y; Sun J; Li W; Gong Y; Zheng X; Cui J; Wang R; Wu J
Eur J Med Chem; 2009 Nov; 44(11):4772-7. PubMed ID: 19615790
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase synthesis and pharmacological evaluation of novel nucleoside-tethered dinuclear platinum(II) complexes.
D'Errico S; Oliviero G; Piccialli V; Amato J; Borbone N; D'Atri V; D'Alessio F; Di Noto R; Ruffo F; Salvatore F; Piccialli G
Bioorg Med Chem Lett; 2011 Oct; 21(19):5835-8. PubMed ID: 21855340
[TBL] [Abstract][Full Text] [Related]
11. Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.
Ding S; Qiao X; Kucera GL; Bierbach U
J Med Chem; 2012 Nov; 55(22):10198-203. PubMed ID: 23074987
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore.
Martins ET; Baruah H; Kramarczyk J; Saluta G; Day CS; Kucera GL; Bierbach U
J Med Chem; 2001 Dec; 44(25):4492-6. PubMed ID: 11728195
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study of arylsulfonylimidazolidinones as anticancer agents.
Sharma VK; Lee KC; Venkateswararao E; Joo C; Kim MS; Sharma N; Jung SH
Bioorg Med Chem Lett; 2011 Nov; 21(22):6829-32. PubMed ID: 21983438
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
Karki R; Thapa P; Kang MJ; Jeong TC; Nam JM; Kim HL; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 May; 18(9):3066-77. PubMed ID: 20392646
[TBL] [Abstract][Full Text] [Related]
17. A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
Hess SM; Anderson JG; Bierbach U
Bioorg Med Chem Lett; 2005 Jan; 15(2):443-6. PubMed ID: 15603970
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of modified acridines: the effect of N- and O- substituent in the nitrogenated ring on antitumor activity.
Sánchez I; Reches R; Caignard DH; Renard P; Pujol MD
Eur J Med Chem; 2006 Mar; 41(3):340-52. PubMed ID: 16413635
[TBL] [Abstract][Full Text] [Related]
19. cis-Dichloroplatinum(II) complexes tethered to dibenzo[c,h][1,6]naphthyridin-6-ones: synthesis and cytotoxicity in human cancer cell lines in vitro.
Desbois N; Pertuit D; Moretto J; Cachia C; Chauffert B; Bouyer F
Eur J Med Chem; 2013 Nov; 69():719-27. PubMed ID: 24095763
[TBL] [Abstract][Full Text] [Related]
20. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
